Electro-Haptic Stimulation: A New Approach for Improving Cochlear-Implant Listening
Overview
Authors
Affiliations
Cochlear implants (CIs) have been remarkably successful at restoring speech perception for severely to profoundly deaf individuals. Despite their success, several limitations remain, particularly in CI users' ability to understand speech in noisy environments, locate sound sources, and enjoy music. A new multimodal approach has been proposed that uses haptic stimulation to provide sound information that is poorly transmitted by the implant. This augmenting of the electrical CI signal with haptic stimulation (electro-haptic stimulation; EHS) has been shown to improve speech-in-noise performance and sound localization in CI users. There is also evidence that it could enhance music perception. We review the evidence of EHS enhancement of CI listening and discuss key areas where further research is required. These include understanding the neural basis of EHS enhancement, understanding the effectiveness of EHS across different clinical populations, and the optimization of signal-processing strategies. We also discuss the significant potential for a new generation of haptic neuroprosthetic devices to aid those who cannot access hearing-assistive technology, either because of biomedical or healthcare-access issues. While significant further research and development is required, we conclude that EHS represents a promising new approach that could, in the near future, offer a non-invasive, inexpensive means of substantially improving clinical outcomes for hearing-impaired individuals.
Fletcher M, Akis E, Verschuur C, Perry S Sci Rep. 2024; 14(1):15029.
PMID: 38951556 PMC: 11217272. DOI: 10.1038/s41598-024-65510-6.
Fletcher M, Perry S, Thoidis I, Verschuur C, Goehring T Sci Rep. 2024; 14(1):7357.
PMID: 38548750 PMC: 10978864. DOI: 10.1038/s41598-024-57312-7.
Fletcher M, Akis E, Verschuur C, Perry S Sci Rep. 2024; 14(1):4889.
PMID: 38418558 PMC: 10901863. DOI: 10.1038/s41598-024-55429-3.
Fletcher M, Verschuur C, Perry S Sci Rep. 2023; 13(1):13336.
PMID: 37587166 PMC: 10432540. DOI: 10.1038/s41598-023-40509-7.
Improving disease prevention, diagnosis, and treatment using novel bionic technologies.
Manero A, Crawford K, Prock-Gibbs H, Shah N, Gandhi D, Coathup M Bioeng Transl Med. 2023; 8(1):e10359.
PMID: 36684104 PMC: 9842045. DOI: 10.1002/btm2.10359.